The Interstitial Lung Disease Program at Inova Fairfax Medical Campus provides comprehensive care for the entire spectrum of interstitial lung diseases, from mild to advanced-stage diseases requiring lung transplantation – all in a single center.
Our team of nationally recognized leaders in interstitial lung disease can ensure accurate diagnosis of your condition and provide state-of-the-art treatment. Our multi-disciplinary approach to diagnosing patients includes input from multiple pulmonologists, a pulmonary pathologist and thoracic radiologists. Our treatment plans are designed to address all aspects of your lung disease as well as any associated comorbidities including cardiovascular, gastrointestinal, musculoskeletal, and psychological issues. In addition, we can provide access to clinical research trials of the newest potential therapies.
Diseases We Treat Include but Are Not Limited to:
- Acute Interstitial Pneumonitis (AIP)
- Chronic Hypersensitivity Pneumonitis
- Connective Tissue Disease-Associated Interstitial Lung Disease (CT-ILD)
- Cryptogenic Organizing Pneumonia (COP)
- Desquamative Interstitial Pneumonitis (DIP)
- Drug-Induced Lung Injury
- Interstitial pneumonitis with autoimmune features (IPAF)
- Idiopathic Pulmonary Fibrosis (IPF)
- Langherhans Cell Histiocytosis
- Lymphangiomyomatosis (LAM)
- Lymphocytic Interstitial Pneumonitis (LIP)
- Non-specific Interstitial Pneumonitis (NSIP)
- Pleuroparenchymal Fibroelastosis (PPFE)
- Combined pulmonary fibrosis and emphysema (CPFE)
- Pneumoconiosis/Coal Miner’s lung Disease
- Respiratory Bronchiolitis-Associated Interstitial Lung Disease (RB-ILD)
- Sarcoidosis
- Silicosis
- Unclassifiable Interstitial Lung Disease
Our Program Maintains Several Prestigious Certifications:
Accredited Pulmonary Fibrosis Foundation Care Center
World Association of Sarcoidosis and Other Granulomatous Diseases (WASOG) Center of Excellence
